Browse > Article
http://dx.doi.org/10.5352/JLS.2022.32.7.550

Protective Effects of Traditional Korean Medicine Preparations, Herbs, and Active Compounds on the Blood-brain Barrier in Ischemic Stroke Models  

Shin, Su Bin (Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University)
Jang, Seok Ju (Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University)
Lee, Na Gyeong (Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University)
Choi, Byung Tae (Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University)
Shin, Hwa Kyoung (Division of Meridian and Structural Medicine, School of Korean Medicine, Pusan National University)
Publication Information
Journal of Life Science / v.32, no.7, 2022 , pp. 550-566 More about this Journal
Abstract
Stroke is among the leading causes of death and long-term physical and cognitive disabilities worldwide, affecting an estimated 15 million people annually. The pathophysiological process of stroke is complicated by multiple and coordinated events. The breakdown of the blood-brain barrier (BBB) in people with stroke can significantly contribute to the development of ischemic brain injury. Therefore, BBB disruption is recognized as a hallmark of stroke; thus, it is important to develop novel therapeutic strategies that can protect against BBB dysfunction in ischemic stroke. Traditional medicines are composed of natural products, which represent a promising source of new ingredients for the development of conventional medicines. Indeed, several studies have shown the effectiveness of Korean medicine on stroke, highlighting the value of Korean medicinal treatment for ischemic stroke. This review summarizes the current information and underlying mechanisms regarding the ameliorating effects of the formula, decoction, herbs, and active components of traditional Korean medicine on cerebral ischemia-induced BBB disruption. These traditional medicines were shown to have protective effects on the BBB in many cellular and animal ischemia models of stroke, and experiments in various animal species, such as mice and rats. In addition, they showed brain-protective effects by protecting the BBB through the regulation of tight junction proteins and matrix metalloproteinase-9, reducing edema, neuroinflammation, and neuronal cell death. We hope that this review will help promote further investigation into the neuroprotective effects of traditional Korean medicines and stimulate the performance of clinical trials on Korean herbal medicine-derived drugs in patients with stroke.
Keywords
Blood-brain barrier; matrix metalloproteinase; stroke; tight junction protein; traditional Korean medicine;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Yang, W., Zhang, L., Chen, S., Yao, Q., Chen, H., Zhou, J., Chen, W., He, L. and Zhang, Y. 2020. Longshengzhi Capsules improve ischemic stroke outcomes and reperfusion injury via the promotion of anti-inflammatory and neuroprotective effects in MCAO/R rats. Evid. Based Complement. Alternat. Med. 2020, 9654175.
2 Zeng, M., Zhou, H., He, Y., Du, H., Yin, J., Hou, Y., Zhu, J., Zhang, Y., Shao, C., Yang, J. and Wan, H. 2021. Danhong injection enhances the therapeutic effect of mannitol on hemispheric ischemic stroke by ameliorating bloodbrain barrier disruption. Biomed. Pharmacother. 142, 112048.   DOI
3 Zhang, S., Wang, X., Cheng, F., Ma, C., Fan, S., Xu, W., Jin, N., Liu, S., Lv, K. and Wang, Q. 2020. Network pharmacology-based approach to revealing biological mechanisms of qingkailing injection against ischemicstroke: focusing on blood-brain barrier. Evid. Based Complement. Alternat. Med. 2020, 2914579.
4 Zhu, H., Wang, Z., Xing, Y., Gao, Y., Ma, T., Lou, L., Lou, J., Gao, Y., Wang, S. and Wang, Y. 2012. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. J. Ethnopharmacol. 141, 714-720.   DOI
5 Zivin, J. A. 2009. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Ann. Neurol. 66, 6-10.   DOI
6 Sun, Z. Y., Wang, F. J., Guo, H., Chen, L., Chai, L. J., Li, R. L., Hu, L. M., Wang, H. and Wang, S. X. 2019. Shuxuetong injection protects cerebral microvascular endothelial cells against oxygen-glucose deprivation reperfusion. Neural Regen. Res. 14, 783-793.   DOI
7 Tsoi, B., Chen, X., Gao, C., Wang, S., Yuen, S. C., Yang, D. and Shen, J. 2019. Neuroprotective effects and hepatorenal toxicity of Angong Niuhuang Wan against ischemia-reperfusion brain injury in rats. Front. Pharmacol. 10, 593.   DOI
8 Jiang, W., Fu, F., Tian, J., Zhu, H. and Hou, J. 2011. Curculigoside A attenuates experimental cerebral ischemia injury in vitro and vivo. Neuroscience 192, 572-579.   DOI
9 Liu, S., Chang, L. and Wei, C. 2019. The sonic hedgehog pathway mediates Tongxinluo capsule-induced protection against blood-brain barrier disruption after ischaemic stroke in mice. Basic Clin. Pharmacol. Toxicol. 124, 660-669.   DOI
10 Ishida, H., Takemori, K., Dote, K. and Ito, H. 2006. Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function. Am. J. Hypertens. 19, 33-39.   DOI
11 Kim, M. J., Park, K. H., Lee, J. Y., Ha, K. T., Choi, B. T., Baek, J. U., Yun, Y. J., Lee, S. Y. and Shin, H. K. 2019. Weisheng-Tang ameliorates acute ishemic brain damage in mice by maintaining Blood-Brain Barrier integrity. Oxid. Med. Cell. Longev. 2019, 4379732.
12 Li, L., Wang, N., Jin, Q., Wu, Q., Liu, Y. and Wang, Y. 2017. Protection of Tong-Qiao-Huo-Xue Decoction against cerebral ischemic injury through reduction Blood-Brain Barrier permeability. Chem. Pharm. Bull (Tokyo). 65, 1004-1010.   DOI
13 Li, Y., Cai, M., Mao, G. X., Shu, Q. F., Liu, X. B. and Liu, X. L. 2021. Preclinical evidence and possible mechanisms of Rhodiola rosea L. and its components for ischemic stroke: A systematic review and meta-analysis. Front. Pharmacol. 12, 736198.   DOI
14 Lin, M., Sun, W., Gong, W., Ding, Y., Zhuang, Y. and Hou, Q. 2015. Ginsenoside Rg1 protects against transient focal cerebral ischemic injury and suppresses its systemic metabolic changes in cerabral injury rats. Acta Pharmacol. Sin. 5, 277-284.   DOI
15 Koehn, F. E. and Carter, G. T. 2005. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 4, 206-220.   DOI
16 Yin, Y. Y., Li, W. P., Gong, H. L., Zhu, F. F., Li, W. Z. and Wu, G. C. 2010. Protective effect of astragaloside on focal cerebral ischemia/reperfusion injury in rats. Am. J. Chin. Med. 38, 517-527.   DOI
17 Chen, H., Guan, B., Chen, X., Chen, X., Li, C., Qiu, J., Yang, D., Liu, K. J., Qi, S. and Shen, J. 2018. Baicalin attenuates Blood-Brain Barrier disruption and hemorrhagic transformation and improves neurological outcome in ischemic stroke rats with delayed t-PA treatment: Involvement of ONOO(-)-MMP-9 pathway. Transl. Stroke Res. 9, 515-529.   DOI
18 Chen, W., Guo, Y., Yang, W., Zheng, P., Zeng, J. and Tong, W. 2015. Protective effect of ginsenoside Rb1 on integrity of blood-brain barrier following cerebral ischemia. Exp. Brain. Res. 233, 2823-2831.   DOI
19 Jin, Z., Liang, J. and Kolattukudy, P. E. 2021. Tetramethylpyrazine preserves the integrity of Blood-Brain Barrier associated with upregulation of MCPIP1 in a murine model of focal ischemic stroke. Front. Pharmacol. 12, 710358.   DOI
20 Kim, M. J., Lee, S. Y., Hwang, J. Y., Kim, H., Ha, K. T., Choi, B. T., Baek, J. U. and Shin, H. K. 2018. Pretreatment with Shuanghe-Tang Extract attenuates postischemic brain injury and edema in a mouse model of stroke: An analysis of medicinal herbs listed in Dongui Bogam. Oxid. Med. Cell. Longev. 2018, 2479602.
21 Boehme, A. K., Esenwa, C. and Elkind, M. S. 2017. Stroke risk factors, genetics, and prevention. Circ. Res. 120, 472-495.   DOI
22 Xie, W., Wang, X., Xiao, T., Cao, Y., Wu, Y., Yang, D. and Zhang, S. 2021. Protective effects and network analysis of Ginsenoside Rb1 against cerebral ischemia injury: A pharmacological review. Front. Pharmacol. 12, 604811.   DOI
23 Li, M., Li, S. C., Dou, B. K., Zou, Y. X., Han, H. Z., Liu, D. X., Ke, Z. J. and Wang, Z. F. 2020. Cycloastragenol upregulates SIRT1 expression, attenuates apoptosis and suppresses neuroinflammation after brain ischemia. Acta Pharmacol. Sin. 41, 1025-1032.   DOI
24 Li, N., Wang, J., Ma, J., Gu, Z., Jiang, C., Yu, L. and Fu, X. 2015. Neuroprotective effects of Cistanches Herba therapy on patients with moderate Alzheimer's disease. Evid. Based Complement. Alternat. Med. 2015, 103985.
25 Li, Y., Ren, M., Wang, J., Ma, R., Chen, H., Xie, Q., Li, H., Li, J. and Wang, J. 2021. Progress in Borneol intervention for ischemic stroke: A systematic review. Front. Pharmacol. 12, 606682.   DOI
26 Chen, H., He, Y., Chen, S., Qi, S. and Shen, J. 2020. Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology. Pharmacol. Res. 158, 104877.   DOI
27 Wu, S. P., Wang, N. and Zhao, L. 2020. Network pharmacology reveals the mechanism of activity of Tongqiao Huoxue Decoction extract against middle cerebral artery occlusion-induced cerebral ischemia-reperfusion injury. Front. Pharmacol. 11, 572624.
28 Chen, H. J., Shen, Y. C., Shiao, Y. J., Liou, K. T., Hsu, W. H., Hsieh, P. H., Lee, C. Y., Chen, Y. R. and Lin, Y. L. 2015. Multiplex brain proteomic analysis revealed the molecular therapeutic effects of Buyang Huanwu Decoction on cerebral ischemic stroke mice. PLoS One 10, e0140823.   DOI
29 Ahmed, T., Raza, S. H., Maryam, A., Setzer, W. N., Braidy, N., Nabavi, S. F., de Oliveira, M. R. and Nabavi, S. M. 2016. Ginsenoside Rb1 as a neuroprotective agent: A review. Brain Res. Bull. 125, 30-43.   DOI
30 Ballabh, P., Braun, A. and Nedergaard, M. 2004. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1-13.   DOI
31 Cao, G., Ye, X., Xu, Y., Yin, M., Chen, H., Kou, J. and Yu, B. 2016. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice. Drug Des. Devel. Ther. 10, 315-325.
32 Cao, J., Wang, K., Lei, L., Bai, L., Liang, R., Qiao, Y., Duan, J., Gao, K., Cao, S., Zhao, C. and Yang, Z. 2020. Astragaloside and/or Hydroxysafflor Yellow A attenuates Oxygen-Glucose deprivation-induced cultured brain microvessel endothelial cell death through downregulation of PHLPP-1. Evid. Based Complement. Alternat. Med. 2020, 3597527.
33 Chang, L. L., Li, C., Li, Z. L., Wei, Z. L., Jia, X. B., Pang, S. T., An, Y. Q., Gu, J. F. and Feng, L. 2020. Carthamus tinctorius L. Extract ameliorates cerebral ischemia-reperfusion injury in rats by regulating matrix metalloproteinases and apoptosis. Indian J. Pharmacol. 52, 108-116.   DOI
34 May, B. H., Lu, C., Bennett, L., Hugel, H. M. and Xue, C. C. 2012. Evaluating the traditional Chinese literature for herbal formulae and individual herbs used for age-related dementia and memory impairment. Biogerontology 13, 299-312.   DOI
35 Li, L., Cheng, S. Q., Guo, W., Cai, Z. Y., Sun, Y. Q., Huang, X. X., Yang, J., Ji, J., Chen, Y. Y., Dong, Y. F., Cheng, H. and Sun, X. L. 2021. Oridonin prevents oxidative stress-induced endothelial injury via promoting Nrf-2 pathway in ischaemic stroke. J. Cell. Mol. Med. 25, 9753-9766.   DOI
36 Chen, Z. X., Xu, Q. Q., Shan, C. S., Shi, Y. H., Wang, Y., Chang, R. C. and Zheng, G. Q. 2019. Borneol for regulating the permeability of the Blood-Brain Barrier in experimental ischemic stroke: Preclinical evidence and possible mechanism. Oxid. Med. Cell. Longev. 2019, 2936737.   DOI
37 Colombo, E. and Farina, C. 2016. Astrocytes: Key regulators of neuroinflammation. Trends Immunol. 37, 608-620.   DOI
38 Hu, S., Wu, Y., Zhao, B., Hu, H., Zhu, B., Sun, Z., Li, P. and Du, S. 2018. Panax notoginseng Saponins protect cerebral microvascular endothelial cells against oxygenglucose deprivation/reperfusion-induced barrier dysfunction via activation of PI3K/Akt/Nrf2 antioxidant signaling pathway. Molecules 23, 2781.   DOI
39 Chen, F. Q., Li, Q., Pan, C. S., Liu, Y. Y., Yan, L., Sun, K., Mao, X. W., Mu, H. N., Wang, M. X., Wang, C. S., Fan, J. Y., Cui, Y. C., Zhang, Y. P., Yang, J. Y., Bai, W. and Han, J. Y. 2016. Kudiezi Injection(®) alleviates blood-brain barrier disruption after ischemia-reperfusion in rats. Microcirculation 23, 426-437.   DOI
40 Lv, L., Liu, Y., Shi, H. F. and Dong, Q. 2009. Qingkailing injection attenuates apoptosis and neurologic deficits in a rat model of intracerebral hemorrhage. J. Ethnopharmacol. 125, 269-273.   DOI
41 Liu, X., Jin, X., Chen, B., Liu, X., Liang, X., Fang, X., Wu, H., Fu, X., Zheng, H., Ding, X., Duan, N. and Zhang, Y. 2018. Effects of Kudiezi Injection on serum inflammatory biomarkers in patients with acute cerebral infarction. Dis. Markers. 2018, 7936736.
42 Liang, W., Huang, X. and Chen, W. 2017. The effects of Baicalin and Baicalein on cerebral ischemia: A review. Aging Dis. 8, 850-867.   DOI
43 Lin, M., Sun, W., Gong, W., Zhou, Z., Ding, Y. and Hou, Q. 2015. Methylophiopogonanone A protects against cerebral ischemia/reperfusion injury and attenuates Blood-Brain Barrier disruption in vitro. PLoS One 10, e0124558.   DOI
44 Liu, G., Liang, Y., Xu, M., Sun, M., Sun, W., Zhou, Y., Huang, X., Song, W., Liang, Y. and Wang, Z. 2021. Protective mechanism of Erigeron breviscapus injection on blood-brain barrier injury induced by cerebral ischemia in rats. Sci. Rep. 11, 18451.   DOI
45 Dong, T., Chen, N., Ma, X., Wang, J., Wen, J., Xie, Q. and Ma, R. 2018. The protective roles of L-borneolum, D-borneolum and synthetic borneol in cerebral ischaemia via modulation of the neurovascular unit. Biomed. Pharmacother. 102, 874-883.   DOI
46 Cui, Z., Liu, S., Hou, L., Sun, Y., Chen, H., Mao, H., Zhao, Y. and Qiao, L. 2021. Effect of Tongfu Xingshen capsule on the endogenous neural stem cells of experimental rats with intracerebral hemorrhage. Mol. Med. Report. 24, 624.   DOI
47 Daneman, R. and Prat, A. 2015. The blood-brain barrier. Cold Spring Harb. Perspect. Biol. 7, a020412.   DOI
48 Daneman, R., Zhou, L., Kebede, A. A. and Barres, B. A. 2010. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566.   DOI
49 Tu, X. K., Yang, W. Z., Liang, R. S., Shi, S. S., Chen, J. P., Chen, C. M., Wang, C. H., Xie, H. S., Chen, Y. and Ouyang, L. Q. 2011. Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochem. Res. 36, 2022-2028.   DOI
50 Seo, H. B., Kang, B. K., Kim, J. H., Choi, Y. W., Hong, J. W., Choi, B. T. and Shin, H. K. 2015. Partially purified components of Uncaria sinensis attenuate blood brain barrier disruption after ischemic brain injury in mice. BMC Complement. Altern. Med. 15, 157.   DOI
51 Wang, B., Lyu, Z., Chan, Y., Li, Q., Zhang, L., Liu, K., Li, Y. and Yu, Z. 2021. Tongxinluo exerts inhibitory effects on pyroptosis and amyloid-β peptide accumulation after cerebral ischemia/reperfusion in rats. Evid. Based Complement. Alternat. Med. 2021, 5788602.
52 Nakagomi, T., Kubo, S., Nakano-Doi, A., Sakuma, R., Lu, S., Narita, A., Kawahara, M., Taguchi, A. and Matsuyama, T. 2015. Brain vascular pericytes following ischemia have multipotential stem cell activity to differentiate into neural and vascular lineage cells. Stem Cells 33, 1962-1974.   DOI
53 Liu, X., Wang, Z., Wang, P., Yu, B., Liu, Y. and Xue, Y. 2013. Green tea polyphenols alleviate early BBB damage during experimental focal cerebral ischemia through regulating tight junctions and PKCalpha signaling. BMC Complement. Altern. Med. 13, 187.   DOI
54 Ma, C., Wang, X., Xu, T., Yu, X., Zhang, S., Liu, S., Gao, Y., Fan, S., Li, C., Zhai, C., Cheng, F. and Wang, Q. 2019. Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 inflammasome signalling pathway. BMC Complement. Altern. Med. 19, 320.   DOI
55 Mao, X. W., Pan, C. S., Huang, P., Liu, Y. Y., Wang, C. S., Yan, L., Hu, B. H., Chang, X., He, K., Mu, H. N., Li, Q., Sun, K., Fan, J. Y. and Han, J. Y. 2015. Levo-tetrahydropalmatine attenuates mouse blood-brain barrier injury induced by focal cerebral ischemia and reperfusion: Involvement of Src kinase. Sci. Rep. 5, 11155.   DOI
56 Nour, M., Scalzo, F. and Liebeskind, D. S. 2013. Ischemiareperfusion injury in stroke. J. Vasc. Interv. Neurol. 1, 185-199.
57 Liu, Z. and Chopp, M. 2016. Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke. Prog. Neurobiol. 144, 103-120.   DOI
58 Ma, C., Wang, X., Xu, T., Zhang, S., Liu, S., Zhai, C., Wang, Z., Mu, J., Li, C., Cheng, F. and Wang, Q. 2020. An integrative pharmacology-based analysis of refined Qingkailing Injection against cerebral ischemic stroke: A novel combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid. Front. Pharmacol. 11, 519.   DOI
59 Michinaga, S. and Koyama, Y. 2015. Pathogenesis of brain edema and investigation into anti-edema drugs. Int. J. Mol. Sci. 16, 9949-9975.   DOI
60 Rosell, A. and Lo, E. H. 2008. Multiphasic roles for matrix metalloproteinases after stroke. Curr. Opin. Pharmacol. 8, 82-89.   DOI
61 Wolburg, H. and Lippoldt, A. 2002. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 38, 323-337.   DOI
62 Wang, L., Li, Z., Zhang, X., Wang, S., Zhu, C., Miao, J., Chen, L., Cui, L. and Qiao, H. 2014. Protective effect of shikonin in experimental ischemic stroke: attenuated TLR4, p-p38MAPK, NF-κB, TNF-α and MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability. Neurochem. Res. 39, 97-106.   DOI
63 Wang, S., Guo, H., Wang, X., Chai, L., Hu, L., Zhao, T., Zhao, B., Tan, X. and Jia, F. 2014. Pretreatment with Danhong injection protects the brain against ischemia-reperfusion injury. Neural Regen. Res. 9, 1453-1459.   DOI
64 Woodruff, T. M., Thundyil, J., Tang, S.-C., Sobey, C. G., Taylor, S. M. and Arumugam, T. V. 2011. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol. Neurodegener. 6, 11.   DOI
65 Tan, F., Fu, W., Cheng, N., Meng, D. I. and Gu, Y. 2015. Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion. Exp. Ther. Med. 9, 1757-1762.   DOI
66 Wang, F., Li, R., Tu, P., Chen, J., Zeng, K. and Jiang, Y. 2020. Total glycosides of Cistanche deserticola promote neurological function recovery by inducing neurovascular regeneration via Nrf-2/Keap-1 pathway in MCAO/R rats. Front. Pharmacol. 11, 236.   DOI
67 Yang, D., Li, S. Y., Yeung, C. M., Chang, R. C., So, K. F., Wong, D. and Lo, A. C. 2012. Lycium barbarum extracts protect the brain from blood-brain barrier disruption and cerebral edema in experimental stroke. PLoS One 7, e33596.   DOI
68 Bai, X., Tan, T. Y., Li, Y. X., Li, Y., Chen, Y. F., Ma, R., Wang, S. Y., Li, Q. and Liu, Z. Q. 2020. The protective effect of cordyceps sinensis extract on cerebral ischemic injury via modulating the mitochondrial respiratory chain and inhibiting the mitochondrial apoptotic pathway. Biomed. Pharmacother. 124, 109834.   DOI
69 Xie, W., Zhu, T., Dong, X., Nan, F., Meng, X., Zhou, P., Sun, G. and Sun, X. 2019. HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways. Biomolecules 9, 512.   DOI
70 Xue, Q., Liu, Y., He, R., Yang, S., Tong, J., Li, X., Chen, Y. and Xu, X. 2016. Lyophilized powder of Catalpol and Puerarin protects neurovascular unit from stroke. Int. J. Biol. Sci. 12, 367-380.   DOI
71 Cao, G., Jiang, N., Hu, Y., Zhang, Y., Wang, G., Yin, M., Ma, X., Zhou, K., Qi, J., Yu, B. and Kou, J. 2016. Ruscogenin attenuates cerebral ischemia-induced Blood-Brain Barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Int. J. Mol. Sci. 17, 1418.   DOI
72 Chang, L., Hu, L., Wei, C., Zhang, H. and Liu, S. 2020. Chinese medicine Tongxinluo capsule protects against blood-brain barrier disruption after ischemic stroke by inhibiting the low-density lipoprotein receptor-related protein 1 pathway in mice. J. Stroke Cerebrovasc. Dis. 29, 105071.   DOI
73 Hughes, R. E., Tadi, P. and Bollu, P. C. 2022. TPA Therapy, StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC.: Treasure Island (FL).
74 Yang, P., Tian, Y. M., Deng, W. X., Cai, X., Liu, W. H., Li, L. and Huang, H. Y. 2019. Sijunzi decoction may decrease apoptosis via stabilization of the extracellular matrix following cerebral ischaemia-reperfusion in rats. Exp. Ther. Med. 18, 2805-2812.
75 Dou, B., Zhou, W., Li, S., Wang, L., Wu, X., Li, Y., Guan, H., Wang, C., Zhu, S., Ke, Z., Huang, C. and Wang, Z. 2018. Buyang Huanwu Decoction attenuates infiltration of Natural Killer cells and protects against ischemic brain injury. Cell. Physiol. Biochem. 50, 1286-1300.   DOI
76 Fan, F., Yang, L., Li, R., Zou, X., Li, N., Meng, X., Zhang, Y. and Wang, X. 2020. Salidroside as a potential neuroprotective agent for ischemic stroke: a review of sources, pharmacokinetics, mechanism and safety. Biomed. Pharmacother. 129, 110458.   DOI
77 Ni, C., Zeng, N., Xu, F., Gou, L., Liu, J., Wang, J. and Xia, H. 2011. Effects of aromatic resuscitation drugs on blood brain barrier in cerebral ischemia-reperfusion injury model rats. Zhongguo Zhong Yao Za Zhi 36, 2562-2566.
78 Park, M. Y., Jung, Y. S., Park, J. H., Choi, Y. W., Lee, J., Kim, C. M., Baek, J. U., Choi, B. T. and Shin, H. K. 2015. PMC-12, a prescription of Traditional Korean Medicine, improves Amyloid β-Induced cognitive deficits through modulation of neuroinflammation. Evid. Based Complement. Alternat. Med. 2015, 768049.
79 Forster, A., Brown, L., Smith, J., House, A., Knapp, P., Wright, J. J. and Young, J. 2012. Information provision for stroke patients and their caregivers. Cochrane Database Syst. Rev. 11, Cd001919.
80 He, F., Duan, X., Dai, R., Wang, W., Yang, C. and Lin, Q. 2016. Protective effects of ethyl acetate extraction from Gastrodia elata blume on blood-brain barrier in focal cerebral ischemia reperfusion. Afr. J. Tradit. Complement. Altern. Med. 13, 199-209.   DOI
81 Zuo, W., Yan, F., Zhang, B., Hu, X. and Mei, D. 2018. Salidroside improves brain ischemic injury by activating PI3K/Akt pathway and reduces complications induced by delayed tPA treatment. Eur. J. Pharmacol. 830, 128-138.   DOI
82 Qu, Y. Z., Li, M., Zhao, Y. L., Zhao, Z. W., Wei, X. Y., Liu, J. P., Gao, L. and Gao, G. D. 2009. Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats. Eur. J. Pharmacol. 606, 137-141.   DOI
83 Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., Djousse, L., Elkind, M. S. V., Ferguson, J. F., Fornage, M., Khan, S. S., Kissela, B. M., Knutson, K. L., Kwan, T. W., Lackland, D. T., Lewis, T. T., Lichtman, J. H., Longenecker, C. T., Loop, M. S., Lutsey, P. L., Martin, S. S., Matsushita, K., Moran, A. E., Mussolino, M. E., Perak, A. M., Rosamond, W. D., Roth, G. A., Sampson, U. K. A., Satou, G. M., Schroeder, E. B., Shah, S. H., Shay, C. M., Spartano, N. L., Stokes, A., Tirschwell, D. L., VanWagner, L. B. and Tsao, C. W. 2020. Heart disease and stroke statistics-2020 update: A report from the American Heart Association. Circulation 141, e139-e596.
84 Choi, M. J., Choi, B. T., Shin, H. K., Shin, B. C., Han, Y. K. and Baek, J. U. 2015. Establishment of a comprehensive list of candidate antiaging medicinal herb used in Korean Medicine by text mining of the classical Korean Medical literature, "Dongeuibogam," and preliminary evaluation of the antiaging effects of these herbs. Evid. Based Complement. Alternat. Med. 2015, 873185.
85 Zhou, Y., Li, H. Q., Lu, L., Fu, D. L., Liu, A. J., Li, J. H. and Zheng, G. Q. 2014. Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression. Phytomedicine 21, 998-1003.   DOI